Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
31,043,093
-
Shares change
-
+647,252
-
Total reported value, excl. options
-
$1,022,845,909
-
Value change
-
+$25,560,178
-
Number of buys
-
102
-
Number of sells
-
80
-
Price
-
$32.95
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2015
As of 30 Jun 2015 Emergent BioSolutions Inc. - Common Stock (EBS) had 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,043,093 shares of stock of the company.
Largest 10 holders included Bank of New York Mellon Corp, VANGUARD GROUP INC, Broadfin Capital, LLC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., LOOMIS SAYLES & CO L P, FIDUCIARY MANAGEMENT ASSOCIATES LLC, and GLENMEDE TRUST CO NA.
This table shows 181 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.